176 related articles for article (PubMed ID: 18023942)
1. Evaluation of the clinical performance of a new intradermal vaccine administration technique and associated delivery system.
Laurent PE; Bonnet S; Alchas P; Regolini P; Mikszta JA; Pettis R; Harvey NG
Vaccine; 2007 Dec; 25(52):8833-42. PubMed ID: 18023942
[TBL] [Abstract][Full Text] [Related]
2. Safety and efficacy of a novel microneedle device for dose sparing intradermal influenza vaccination in healthy adults.
Van Damme P; Oosterhuis-Kafeja F; Van der Wielen M; Almagor Y; Sharon O; Levin Y
Vaccine; 2009 Jan; 27(3):454-9. PubMed ID: 19022318
[TBL] [Abstract][Full Text] [Related]
3. Intradermal vaccination for infants and children.
Saitoh A; Aizawa Y
Hum Vaccin Immunother; 2016 Sep; 12(9):2447-55. PubMed ID: 27135736
[TBL] [Abstract][Full Text] [Related]
4. Clinical performance and safety of adapters for intradermal delivery with conventional and autodisable syringes.
Tsals I; Jarrahian C; Snyder FE; Saganic L; Saxon E; Zehrung D; Zimmerman G; Papania M; Klaff L
Vaccine; 2015 Sep; 33(37):4705-11. PubMed ID: 25964169
[TBL] [Abstract][Full Text] [Related]
5. Fluzone(®) Intradermal vaccine: a promising new chance to increase the acceptability of influenza vaccination in adults.
Ansaldi F; de Florentiis D; Durando P; Icardi G
Expert Rev Vaccines; 2012 Jan; 11(1):17-25. PubMed ID: 22149703
[TBL] [Abstract][Full Text] [Related]
6. Acceptability of fluzone intradermal vaccine to patients and vaccine administrators.
Foy JE; Hendriksz T; Malouf P; Tobin A
J Am Osteopath Assoc; 2013 Feb; 113(2):134-43. PubMed ID: 23412675
[TBL] [Abstract][Full Text] [Related]
7. Intradermal delivery for vaccine dose sparing: overview of current issues.
Zehrung D; Jarrahian C; Wales A
Vaccine; 2013 Jul; 31(34):3392-5. PubMed ID: 23176978
[TBL] [Abstract][Full Text] [Related]
8. Echographic measurement of skin thickness in sites suitable for intradermal vaccine injection in infants and children.
Ploin D; Schwarzenbach F; Dubray C; Nicolas JF; Goujon C; Trong MD; Laurent PE
Vaccine; 2011 Oct; 29(46):8438-42. PubMed ID: 21821081
[TBL] [Abstract][Full Text] [Related]
9. Devices for intradermal vaccination.
Kis EE; Winter G; Myschik J
Vaccine; 2012 Jan; 30(3):523-38. PubMed ID: 22100637
[TBL] [Abstract][Full Text] [Related]
10. Skin thickness in young infants and adolescents: Applications for intradermal vaccination.
Saitoh A; Aizawa Y; Sato I; Hirano H; Sakai T; Mori M
Vaccine; 2015 Jun; 33(29):3384-91. PubMed ID: 25944297
[TBL] [Abstract][Full Text] [Related]
11. High frequency ultrasound to assess skin thickness in healthy adults.
Van Mulder TJ; de Koeijer M; Theeten H; Willems D; Van Damme P; Demolder M; De Meyer G; Beyers KC; Vankerckhoven V
Vaccine; 2017 Mar; 35(14):1810-1815. PubMed ID: 27496276
[TBL] [Abstract][Full Text] [Related]
12. Delivery systems for intradermal vaccination.
Kim YC; Jarrahian C; Zehrung D; Mitragotri S; Prausnitz MR
Curr Top Microbiol Immunol; 2012; 351():77-112. PubMed ID: 21472533
[TBL] [Abstract][Full Text] [Related]
13. Performance comparison of a novel intradermal injection system with the Mantoux technique.
Tanizaki H; Nakashima C; Shimizuhira C; Miyachi Y; Kabashima K
J Dermatol Sci; 2015 Sep; 79(3):310-3. PubMed ID: 26187265
[No Abstract] [Full Text] [Related]
14. Echographic measurement of skin thickness in adults by high frequency ultrasound to assess the appropriate microneedle length for intradermal delivery of vaccines.
Laurent A; Mistretta F; Bottigioli D; Dahel K; Goujon C; Nicolas JF; Hennino A; Laurent PE
Vaccine; 2007 Aug; 25(34):6423-30. PubMed ID: 17640778
[TBL] [Abstract][Full Text] [Related]
15. Intradermal vaccine delivery: will new delivery systems transform vaccine administration?
Lambert PH; Laurent PE
Vaccine; 2008 Jun; 26(26):3197-208. PubMed ID: 18486285
[TBL] [Abstract][Full Text] [Related]
16. Intradermal vaccination with un-adjuvanted sub-unit vaccines triggers skin innate immunity and confers protective respiratory immunity in domestic swine.
Le Luduec JB; Debeer S; Piras F; Andréoni C; Boudet F; Laurent P; Kaiserlian D; Dubois B
Vaccine; 2016 Feb; 34(7):914-22. PubMed ID: 26768129
[TBL] [Abstract][Full Text] [Related]
17. Intradermal influenza vaccine administered using a new microinjection system produces superior immunogenicity in elderly adults: a randomized controlled trial.
Holland D; Booy R; De Looze F; Eizenberg P; McDonald J; Karrasch J; McKeirnan M; Salem H; Mills G; Reid J; Weber F; Saville M
J Infect Dis; 2008 Sep; 198(5):650-8. PubMed ID: 18652550
[TBL] [Abstract][Full Text] [Related]
18. Preclinical evaluation of performance, safety and usability of VAX-ID®, a novel intradermal injection device.
Beyers KCL; Rbeihat MNM; S Vasconcelos D; Pasmans D; Verwulgen S; Vankerckhoven VVJ
Vaccine; 2023 Jul; 41(31):4609-4615. PubMed ID: 37330370
[TBL] [Abstract][Full Text] [Related]
19. Usability evaluation of intradermal adapters (IDA).
Tsals I
Vaccine; 2017 Mar; 35(14):1797-1801. PubMed ID: 27496277
[TBL] [Abstract][Full Text] [Related]
20. The immunological effects of intradermal particle-based vaccine delivery using a novel microinjection needle studied in a human skin explant model.
Beaujean M; Uijen RF; Langereis JD; Boccara D; Dam D; Soria A; Veldhuis G; Adam L; Bonduelle O; van der Wel NN; Luirink J; Pedruzzi E; Wissink J; de Jonge MI; Combadière B
Vaccine; 2023 Mar; 41(13):2270-2279. PubMed ID: 36870875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
